DWM
ABEO icon

Darwin Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Darwin Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160 Hold
26
– – ﹤0.01% 643
2026
Q1 		$116 Hold
26
– – ﹤0.01% 585
2025
Q4 		$137 Hold
26
– – ﹤0.01% 630
2025
Q3 		$137 Hold
26
– – ﹤0.01% 581
2025
Q2 		$147 Hold
26
– – ﹤0.01% 583
2025
Q1 		$144 Hold
26
– – ﹤0.01% 617
2024
Q4 		$144 Hold
26
– – ﹤0.01% 617
2024
Q3 		$164 Buy
+26
New +$136 ﹤0.01% 623

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Darwin Wealth Management's ABEO Position: Q2 2026 in Review

Darwin Wealth Management held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 26 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #643.

Darwin Wealth Management first reported a position in ABEO in Q3 2024 and has held it in 8 quarters since. The position peaked at $164 in Q3 2024. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Darwin Wealth Management held 26 shares of Abeona Therapeutics worth $160 as of Q2 2026.
  • Darwin Wealth Management left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #643 holding.
  • Darwin Wealth Management first reported a position in Abeona Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Darwin Wealth Management's Abeona Therapeutics position peaked at $164 in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.